Beloorbayir Biotech Limited
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glemevose 1mg/500mg/0.2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Glemevose 1mg/500mg/0.2mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glemevose 1mg/500mg/0.2mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glemevose 1mg/500mg/0.2mg Tablet.
Glemevose 1mg/500mg/0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glemevose 1mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glemevose 1mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain loss of appetite or yellowing of the eyes or skin (jaundice).
Glemevose 1mg/500mg/0.2mg Tablet is a combination of three medications: Glimepiride, Metformin, and Voglibose. This medication is prescribed for the treatment of type 2 diabetes mellitus (DM). It helps improve blood glucose levels in adults when used alongside a proper diet and regular exercise. Glimepiride increases insulin release from the pancreas, while Metformin reduces glucose production by the liver and improves insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meal) glucose levels.
Common side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Individuals with known allergies to any of the ingredients or excipients in this medication, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis (including diabetic ketoacidosis) should avoid Glemevose 1mg/500mg/0.2mg Tablet.
No, combining Glemevose 1mg/500mg/0.2mg Tablet with alcohol is not advised. It may further lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Glemevose 1mg/500mg/0.2mg Tablet can cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. It is more likely to occur if you miss meals, drink alcohol, overexercise, take other antidiabetic medications simultaneously, or delay food intake.
Store this medicine in its original packaging or container, tightly sealed. Follow instructions on the label or medication pack. Do not share this medication with pets, children, or others.